Levodropropizine
From Wikipedia, the free encyclopedia
![]() |
|
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | R05DB27 (WHO) |
Pharmacokinetic data | |
Protein binding | 11-14% |
Excretion | 83% via urine within 96 h |
Identifiers | |
|
|
CAS Number | 99291-25-5 ![]() |
PubChem (CID) | 65859 |
ChemSpider | 59270 ![]() |
UNII | 3O31P6T4G3 ![]() |
KEGG | D08119 ![]() |
ChEBI | CHEBI:82722 ![]() |
ECHA InfoCard | 100.167.719 |
Chemical and physical data | |
Formula | C13H20N2O2 |
Molar mass | 236.31 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
![]() ![]() |
Levodropropizine is a cough suppressant. It is the levo isomer of dropropizine. It acts as a peripheral antitussive, with no action in the central nervous system.[1] It does not cause side effects such as constipation or respiratory depression which can be produced by opioid antitussives such as codeine and its derivatives.
References[edit]
- ^ De Blasio, F.; Dicpinigaitis, P. V.; Rubin, B. K.; De Danieli, G.; Lanata, L.; Zanasi, A. (2012). "An observational study on cough in children: Epidemiology, impact on quality of sleep and treatment outcome". Cough. 8 (1): 1. doi:10.1186/1745-9974-8-1. PMC 3274450
. PMID 22269875.
![]() |
This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |